Patents
Patents for C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
10/2012
10/26/2012CA2833320A1 Dibenzothiazepine derivatives and their use in the treatment of cns disorders
10/17/2012CN101891707B Method for preparing Quetiapine or pharmaceutically acceptable fumarate thereof
10/10/2012EP2508515A1 Ligands for g-protein coupled receptors
09/2012
09/19/2012CN102686602A Lanthionine derivative
08/2012
08/02/2012WO2012063085A3 Drug derivatives
07/2012
07/11/2012CN102558093A Agents for preventing and treating disorders involving modulation of the ryr receptors
06/2012
06/12/2012US8198268 Tianeptine sulfate salt forms and methods of making and using the same
05/2012
05/30/2012CN101337948B 1,5-benzothiazepines compounds, preparation method and application thereof
05/18/2012CA2816000A1 Drug derivatives
05/16/2012CN1854128B Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
05/10/2012US20120114588 Ibat inhibitors for treatment of metabolic disorders and related conditions
05/02/2012CN102432562A Quetiapine fumarate compound and new preparation method thereof
04/2012
04/25/2012EP1719768B1 Novel benzothiazepine and benzothiepine compounds
04/24/2012US8163730 Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha
04/17/2012US8158618 Dibenzothiazepine derivatives and uses thereof—424
03/2012
03/28/2012CN102391208A New crystal form I of quetiapine fumarate and preparation method thereof
03/27/2012US8143242 Malonamide derivatives with antithrombotic activity
03/22/2012US20120071429 Novel antibacterial agents
02/2012
02/23/2012US20120046198 Ligand Libraries for Screening GPCRs
02/02/2012US20120029188 Substituted Aniline Derivatives
01/2012
01/31/2012US8106023 1,4-benzothiepin-1, 1-dioxide derivatives with improved properties method for producing the same, drugs containing said compounds and the use thereof
01/26/2012US20120022249 Aminodihydrothiazine derivatives
01/24/2012US8101597 Quetiapine salts and their polymorphs
01/24/2012US8101583 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with fluorine, method for producing the same, drugs containing said compounds and use thereof
01/19/2012US20120016116 Aminodihydrothiazine derivatives
01/19/2012US20120015925 Novel benzothiazepine and benzothiepine compounds
01/11/2012EP2403841A1 Process for the preparation of quetiapine fumarate
12/2011
12/28/2011CN102293773A 含有苯并硫氮杂卓和苯并虑平化合物的药物 Benzothiazepine and benzo drugs containing compounds doxepin
12/07/2011EP2392567A1 Benzothiazine derivatives and their use as lxr modulators
12/07/2011EP2250159B1 Process for preparing benzothiazepines from gamma-aminoalkylbenzenes
11/2011
11/29/2011US8067585 Photocoupling; cyclization and sulfonimidation of disulfonyl fluoride compound by reaction with ammonia; heating, alkylation, electrolysis, quaternization, salt formation; chemical intermediates
11/29/2011US8067584 Benzothiazepine derivatives
11/22/2011US8063037 Progesterone receptor modulators
11/03/2011US20110269743 Phenylthiophenyldihydrobenzothiazepine inhibitors of store operated calcium release
11/03/2011CA2795543A1 Chemical compounds
11/02/2011EP1535913B1 Novel quaternary ammonium compounds
11/01/2011US8048876 Process for preparing quetiapine and quetiapine fumarate
10/2011
10/25/2011US8044039 Quetiapine hemifumarate purification by crystallization
10/25/2011US8044038 Crystallization process of quetiapine hemifumarate
10/13/2011WO2011126071A1 Agent for inhibiting viral infection and/or treating infectious disease, and method for inhibiting viral infection and/or treating infectious disease
10/11/2011US8034805 Methods for the preparation of salts of 2-[2-(4-dibenzo[B,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxyl]ethanol (quetiapine) and for the purification thereof
10/06/2011WO2011121602A1 Process for preparation of dibenzothiazepinone compounds
10/05/2011CN102206195A Crystalline quetiapine fumarate and pharmaceutical compositions thereof
09/2011
09/28/2011EP2367806A2 Process and intermediates for the preparation of 7-((3-chloro-6-methyl-5,5-dioxo-6,11-dihydrodibenzo(c,f)(1,2) thiazepin-11-yl)amino)heptanoate
09/21/2011CN101360725B Solid formulations
09/20/2011US8022203 Amino derivatives of beta-homoandrostanes and beta-heteroandrostanes
09/20/2011US8022059 Indazole acrylic acid amide compound
09/20/2011US8022058 Agents for preventing and treating disorders involving modulation of the RyR receptors
09/20/2011CA2115828C Calcium receptor active molecules
09/09/2011WO2011107248A1 NOVEL COMPOUNDS FOR MODULATION OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ GAMMA, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASE
09/06/2011US8012943 Antibacterial agents
08/2011
08/24/2011CN102161644A Ligands for g-protein coupled receptors
08/18/2011WO2010070510A3 A process for preparing quetiapine fumarate
08/17/2011EP2357474A1 Lurasidone for use in the treatment of memory or learning dysfunction by schizophrenia
08/11/2011US20110195945 Compounds, Compositions and Methods for Treating or Preventing Hypoxic or Ischemic Injury
08/03/2011EP2349276A2 Hiv integrase inhibitors
07/2011
07/20/2011CN1930137B Novel benzothiazepine and benzothiepine compounds
07/20/2011CN102131791A Dibenzothiazepine derivatives and use thereof
07/14/2011US20110172190 Agents for preventing and treating disorders involving modulation of the ryanodine receptors
07/13/2011EP2343286A1 Dibenzo[b,f][1,4]oxazepine derivatives as inhibitors of histone deacetylase
07/07/2011WO2011081184A1 Lanthionine derivative
07/07/2011CA2784310A1 Lanthionine derivatives
07/05/2011US7973030 Benzothiazepine and benzothiepine compounds
06/2011
06/28/2011US7968707 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection
06/16/2011US20110144087 Short acting benzothiazepine calcium channel blockers and uses thereof
06/15/2011EP2330895A1 Short acting benzothiazepine calcium channel blockers and uses thereof
05/2011
05/31/2011CA2493390C A process for production of high-purity enamines
05/12/2011US20110112068 Human immunodeficiency virus protease inhibitors
04/2011
04/28/2011US20110098273 Oligomer-Calcium Channel Blocker Conjugates
04/20/2011EP2311464A1 Agents for preventing and treating disorders involving modulation of the ryr receptors
04/13/2011EP2307389A1 Dibenzothiazepine derivatives and use thereof
03/2011
03/30/2011EP0933354B1 Calcium receptor-active compounds
03/24/2011WO2011034051A1 Novel cyclic squaramide derivatives
03/17/2011US20110065667 Phenylpyrazole derivatives
03/08/2011US7902355 Process for the preparation of an 11-(4-substituted-1-piperazinyl)dibenzo[b,f][1,4]thiazepine derivative
02/2011
02/16/2011CN101977902A Process for preparing benzothiazepines from gamma-aminoalkylbenzenes
02/08/2011CA2480940C Non-steroidal progesterone receptor modulators
02/08/2011CA2431461C 1,5 benzothiazepines and their use as antihyperlipidemics
02/02/2011CN101962369A Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders
02/01/2011US7879840 Ryanodine receptors (RyRs) modulators comprising 1,4-benzothiazepine derivatives, that regulate calcium channel functioning in cells, used for the treatment of cardiovascular disorders and muscular disorders
02/01/2011CA2459449C Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia
01/2011
01/19/2011EP1664009B1 Preparation method for quetiapine
01/04/2011US7863441 cyclization using phosphorus oxychloride; antipsychotic or neuroleptic agent for psychological disorders
01/04/2011US7863277 antipsychotic (ziprasidone and quetiapine) encapsulated in cyclodextrin, and a dermatologically acceptable carrier consisting of ethoxy diglycol, lecithin soya, isopropyl palmitate, poloxamer and water; schizophrenia; Bipolar disorders
12/2010
12/28/2010US7858777 comprises the ring closure and deprotection of an intermediate; 11-(4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]dibenzo[b,f]-1,4-thiazepine; used as an antipsychotic or neuroleptic
12/28/2010US7858776 (2,3-cis)-3-amino-2-phenyl-2,3-dihydro-1,5-benzoxazepin-4(5H)-one; for treatment of neurological disorders related to amyloid beta protein production such as Alzheimer's disease; inhibit gamma secretase and thereby inhibit the production of amyloid beta protein
12/22/2010CN101925587A Process for preparation of quetiapine
12/09/2010US20100311718 Treatment of Psychoses with Dibenzothiazepine Antipsychotic
12/07/2010US7847094 Industrial preparation of 11-[4-{2-(2-hydroxyethoxy) ethyl}-1-piperazinyl] dibenzo [b,f]-[1,4]thiazepine
12/02/2010US20100305094 Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha
11/2010
11/24/2010EP2253315A1 Alkoxyphenylpropanoic acid derivatives
11/24/2010CN101891707A Method for preparing Quetiapine or pharmaceutically acceptable fumarate thereof
11/24/2010CN101891706A 3,4-dihydrobenzo[f][1,4]thiazepine compound or salts of same and medical use of same
11/17/2010EP2250159A1 Process for preparing benzothiazepines from gamma-aminoalkylbenzenes
11/03/2010EP2245021A1 A process for the preparation of quetiapine
10/2010
10/19/2010US7816408 (N-{5-[(4-chlorophenyl)thio]pentyl}-N-[(1R)-1-(1-naphthyl)ethyl]amine); mimics/blocks effect of extracellular calcium in parathyroid cells, juxtaglomerular/proximal tubule kidney cells, parafollicular thyroid cells, bone osteoclasts, keratinocytes or placental trophoblasts; hyperparathyroidism
10/14/2010WO2010070667A3 Process and intermediates for the preparation of 7-( (3-chloro-6-methyl-5,5-dioxo-6,ll-dihydrodibenzo (c, f) (1,2) thiazepin-11-yd amino) heptanoate
10/07/2010US20100256082 Metallo-hydrolase inhibitors using metal binding moietes in combination with targeting moieties
10/05/2010US7807827 reacting 2-(4-dibenzo[b,f][1,4]thiazepine-11-il-piperazine-1-il)ethanol and 2-(2-chloroethoxy)-tetrahydro-2H-pyran and tetrabutylammonium hydrogen sulfate in presence of NaOH base to form quetiapine; high degree of purity; antipsychotic or neuroleptic
09/2010
09/28/2010US7803792 benzothiazepine compounds having a thioamide bond and a quaternary ammonium substituent, exhibiti a potent ileal bile acid transporter inhibiting activity, used for for treating hyperlipidemia or arteriosclerosis
1 2 3 4 5 6 7 8 9 10 11 12 ... 20